Group One Trading’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-9,478
| Closed | -$36K | – | 2684 |
|
2020
Q1 | $36K | Sell |
9,478
-30,008
| -76% | -$114K | ﹤0.01% | 898 |
|
2019
Q4 | $201K | Buy |
39,486
+16,701
| +73% | +$85K | ﹤0.01% | 633 |
|
2019
Q3 | $115K | Buy |
+22,785
| New | +$115K | ﹤0.01% | 712 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 2387 |
|
2019
Q1 | – | Sell |
-70,779
| Closed | -$297K | – | 2346 |
|
2018
Q4 | $297K | Sell |
70,779
-5,650
| -7% | -$23.7K | ﹤0.01% | 518 |
|
2018
Q3 | $479K | Buy |
76,429
+12,863
| +20% | +$80.6K | ﹤0.01% | 460 |
|
2018
Q2 | $511K | Buy |
63,566
+41,800
| +192% | +$336K | ﹤0.01% | 430 |
|
2018
Q1 | $162K | Sell |
21,766
-45,444
| -68% | -$338K | ﹤0.01% | 637 |
|
2017
Q4 | $400K | Buy |
67,210
+23,220
| +53% | +$138K | ﹤0.01% | 522 |
|
2017
Q3 | $324K | Buy |
43,990
+25,362
| +136% | +$187K | ﹤0.01% | 525 |
|
2017
Q2 | $126K | Buy |
+18,628
| New | +$126K | ﹤0.01% | 717 |
|
2017
Q1 | – | Sell |
-12,390
| Closed | -$107K | – | 2049 |
|
2016
Q4 | $107K | Sell |
12,390
-5,876
| -32% | -$50.7K | ﹤0.01% | 657 |
|
2016
Q3 | $116K | Buy |
+18,266
| New | +$116K | ﹤0.01% | 616 |
|
2016
Q2 | – | Sell |
-33,796
| Closed | -$147K | – | 1970 |
|
2016
Q1 | $147K | Buy |
33,796
+19,325
| +134% | +$84.1K | ﹤0.01% | 509 |
|
2015
Q4 | $89K | Buy |
14,471
+10,900
| +305% | +$67K | ﹤0.01% | 748 |
|
2015
Q3 | $20K | Sell |
3,571
-34,080
| -91% | -$191K | ﹤0.01% | 1114 |
|
2015
Q2 | $281K | Buy |
37,651
+18,347
| +95% | +$137K | ﹤0.01% | 523 |
|
2015
Q1 | $115K | Buy |
+19,304
| New | +$115K | ﹤0.01% | 652 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 2033 |
|
2014
Q3 | – | Hold |
0
| – | – | – | 2082 |
|
2014
Q2 | – | Hold |
0
| – | – | – | 2095 |
|
2014
Q1 | – | Sell |
-41,603
| Closed | -$222K | – | 2073 |
|
2013
Q4 | $222K | Sell |
41,603
-847
| -2% | -$4.52K | ﹤0.01% | 547 |
|
2013
Q3 | $214K | Buy |
42,450
+28,866
| +213% | +$146K | ﹤0.01% | 501 |
|
2013
Q2 | $61K | Buy |
+13,584
| New | +$61K | ﹤0.01% | 796 |
|